Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years With Luminal A-like Early Stage Breast Cancer (EUROPA): a Randomized Phase 3 Trial

NCT04134598 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria Careggi as lead sponsor.

NCT NCT04134598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04134598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years With Luminal A-like Early Stage Breast Cancer (EUROPA): a Randomized Phase 3 Trial
Lead sponsor
Azienda Ospedaliero-Universitaria Careggi
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 8, 2021
Completion date
March 31, 2030
Enrollment
926 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer